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First time in history…
“Never before in history has there been a situation 
where a bite from a mosquito could result in a 
devastating malformation.”
– Dr. Tom Frieden, CDC Director 
Fortune, April 13, 2016
“…the last time an infectious pathogen (rubella 
virus) caused an epidemic of congenital defects 
was more than 50 years ago…”
– New England Journal of Medicine, April 13, 2016
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Zika: The Basics
What is Zika virus?
• Single-stranded RNA virus
• Closely related to dengue, yellow fever, 
Japanese encephalitis, and West Nile viruses
• Primarily transmitted by the bite of two Aedes
species mosquitoes
• Aedes aegypti and Aedes albopictus mosquitoes
• Additional modes of transmission
• Intrauterine and perinatal transmission (mother to 
fetus)
• Sexual transmission
• Laboratory exposure
• Probable: Blood transfusion
Aedes aegypti mosquito
Aedes albopictus mosquito 
As of December 14, 2016
http://www.cdc.gov/zika/geo/active-countries.html 
Where is Zika Now?
Signs and Symptoms
• Clinical illness is usually mild
• Most common symptoms are:
• Fever
• Rash
• Joint pain
• Conjunctivitis
• Symptoms last several days to a week
• Severe disease is uncommon
• Fatalities are rare
• Once infected, a person is likely to be 
protected from future infections
Clinical Management
• No vaccine or specific antiviral treatment
• Treat the symptoms
• Rest
• Drink fluids to prevent dehydration
• Take medicine such as acetaminophen to 
reduce fever and pain
• Avoid aspirin and other non-steroidal anti-
inflammatory drugs (NSAIDS) until dengue can 
be ruled out to reduce the risk of bleeding
Zika, Pregnancy, and Congenital Zika Infection
Zika Virus Infection in Pregnant Women
• Pregnant women can be infected
• Through the bite of an infected mosquito
• Through sex without a condom with an infected partner
• If a woman is infected around conception
• Zika might present risk to fetus
• If infected during pregnancy
• Zika can be passed to the fetus during pregnancy or 
around the time of birth
Zika Virus in Pregnancy
• Infection can occur in any trimester
• No evidence of increased susceptibility to 
Zika virus
• The clinical course is similar in pregnant 
women and in non-pregnant people
Centers for Disease Control and Prevention, CDC Health Advisory:  Recognizing, Managing, and Reporting Zika Virus Infections in Travelers Returning from Central America, South America, the Caribbean and Mexico, 2016.
Besnard, M., et al., Evidence of Perinatal Transmission of Zika Virus, French Polynesia, December 2013 and February 2014. Euro Surveill, 2014. 19(14): p. 1-5.
Oliveira Melo, A., et al., Zika Virus Intrauterine Infection Causes Fetal Brain Abnormality and Microcephaly: Tip of the Iceberg? Ultrasound in Obstetrics & Gynecology, 2016. 47(1): p. 6-7.
CDC Lab Confirms Zika In Fetal Tissues
• Zika virus has been shown to 
be present in fetal tissue
• Evidence of Zika virus has 
been detected in
• Amniotic fluid
• Placenta 
• Fetal brain tissue
• Products of conception
• Zika virus has been found to 
continue to replicate in 
infants' brains after birth 
(Bhatnagar et.al., 2017)
Immunohistochemical staining of Zika virus antigen (red stain)  in fetal 
brain tissue. This staining is present in the same areas where neuronal cell 
death/necrosis was identified by microscopic review of tissue morphology.
Bhatnagar J, Rabeneck DB, Martines RB,Reagan-Steiner S, Ermias Y, Estetter LBC, et al. Zika
virus RNA replication and persistence in brain and placental tissue. Emerg Infect Dis. 2017 
Mar [Epub ahead of print].
Reference/attribution for image: Ritter JM, Martines RB, Zaki SR. Zika Virus: Pathology From 
the Pandemic. Arch Pathol Lab Med. 2016 Oct 5. [Epub ahead of print]
Zika is a Cause of Microcephaly
Potential Risk of Birth Defects Related to Zika
• Among pregnant women in the United States with 
laboratory evidence of possible Zika virus infection:
• Overall about 6% of fetuses or infants had birth defects 
potentially related to Zika virus
• The proportion of pregnancies with birth defects was similar 
(around 6%) among symptomatic and asymptomatic 
pregnant women 
• Among women with infection in the 1st trimester of 
pregnancy, birth defects were reported in 11% of fetuses or 
infants
Honein MA, Dawson AL, Petersen EE et al. Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy. JAMA. 2016 Dec 15 [Epub
ahead of print] 
Congenital Zika Syndrome
• Pattern of congenital anomalies associated with Zika virus 
infection during pregnancy that includes
• Severe microcephaly (small head size) resulting in a partially 
collapsed skull
• Thin cerebral cortices with subcortical calcifications
• Eye anomalies, including macular scarring and focal pigmentary 
retinal mottling
• Congenital contractures or limited range of joint motion
• Marked early hypertonia, or too much muscle tone, and 
symptoms of extrapyramidal involvement
• Infants with normal head circumference at birth may: 
• Have brain abnormalities consistent with congenital Zika
syndrome 
• Develop mirocephaly after birth
Potential Risk of Microcephaly 
• 1 - 13% estimated risk of microcephaly due to Zika virus 
infection in first trimester
• Modeling based on current outbreak in Bahia, Brazil
• Not enough data to estimate 2nd or 3rd trimester risk
• Important to remember
• Data are limited (infection rates unknown; microcephaly 
cases still being reported)
• Microcephaly is difficult to detect prenatally
• Microcephaly is only one of a range of possible adverse 
outcomes
Johansson MA, Mier-Y-Teran-Romero L, Reefhuis J, Gilboa SM, Hills SL. Zika and the Risk of Microcephaly. N Engl J Med. 2016 May 25 [Epub ahead of print]. 
Congenital Zika Syndrome without Microcephaly at Birth
• Microcephaly from congenital infection can occur after birth
• The full spectrum of poor outcomes caused by Zika virus infection during pregnancy 
remains unknown
Linden V, Pessoa A, Dobyns WB, et al. Description of 13 Infants Born During October 2015–January 2016 . . . MMWR. 22 Nov 2016. 
CDC Guidance: Infants with Possible Congenital Zika Virus Infection
Infants with Possible Congenital Zika Virus Infection
• Testing for Zika virus infection is recommended for infants born to: 
1) mothers with laboratory evidence of possible Zika virus infection; 
2) infants with findings suggestive of congenital Zika syndrome and a maternal epidemiologic link 
suggesting possible transmission, regardless of maternal testing results
• Congenital Zika virus infection can be diagnosed by RNA nucleic acid testing (NAT) 
• All infants with possible congenital Zika virus infection should have a comprehensive physical exam and 
head ultrasound before hospital discharge regardless of the presence of abnormalities and prenatal 
ultrasound results
Link: http://www.cdc.gov/zika/pdfs/zika_peds.pdf
Infants with Possible Congenital Zika Virus Infection
Recommendations for follow-up depend on whether the infant has abnormalities 
consistent with congenital Zika syndrome
http://www.cdc.gov/zika/pdfs/pediatric-evaluation-follow-up-tool.pdf
Initial Evaluation
Infants with abnormalities consistent with congenital Zika syndrome born to a 
mother with lab evidence of Zika
• Before hospital discharge:
Routine newborn care: physical exam, including occipitofrontal (head) circumference, weight, 
length, a neurologic exam, and universal hearing screen
Head ultrasound
Testing for congenital Zika virus infection
Complete blood count, metabolic panel and liver enzyme testing
Consult with multiple subspecialists
Referral for comprehensive eye exam by an ophthalmologist
Referral for auditory brainstem response (ABR) hearing evaluation
Consider advanced cranial imaging (e.g., MRI)
Consider transfer to hospital with specialty care
• Refer for a comprehensive ophthalmologic exam and evaluation of hearing by ABR 
testing before 1 month of age
https://www.cdc.gov/mmwr/volumes/65/wr/mm6533e2.htm?s_cid=mm6533e2_w
Consult with Specialists
Infants with abnormalities consistent with congenital Zika syndrome and lab 
evidence of Zika
• Neurologist to determine appropriate neuroimaging and additional evaluation
• Infectious disease specialist to evaluate other congenital infections 
• Ophthalmologist  to examine the eye and evaluate for possible cortical visual 
impairment prior to discharge from hospital or within 1 month of birth
• Endocrinologist to evaluate for hypothalamic or pituitary dysfunction
• Clinical geneticist to evaluate for other causes of microcephaly or other anomalies 
if present
Consult with Specialists
Infants with abnormalities consistent with congenital Zika syndrome and lab 
evidence of Zika
Consultation with the following should also be considered: 
• Orthopedist, physiatrist, and physical therapist to manage hypertonia, club 
foot, or arthrogrypotic-like conditions
• Pulmonologist or otolaryngologist to consult about aspiration
• Lactation specialist, nutritionist, gastroenterologist, or speech or occupational 
therapist to manage feeding issues
Outpatient Management
Infants with abnormalities consistent with congenital Zika syndrome and lab 
evidence of Zika
• Establish a medical home to facilitate coordination of care
• Provide routine preventive pediatric health care, including immunizations and 
monthly primary care visits for at least the first 6 months
• Conduct developmental monitoring at each routine visit
• Complete neurologic exam at age 1 and 2 months, then as needed
• Refer patients to developmental specialist and early intervention services
• Repeat ophthalmology exam with retinal assessment at 3 months
• Repeat ABR hearing assessment at age 4–6 months
• Conduct thyroid screening at age 2 weeks and age 3 months
• Provide family support services
• Provide appropriate referrals
Initial Evaluation & Outpatient Management
Infants with lab evidence of Zika and without abnormalities consistent with 
congenital Zika syndrome
• Before hospital discharge infants should receive
• Routine care including monitoring of occipitofrontal circumference, length, and weight
• Outpatient management includes routine follow up and
• Establish medical home 
• Perform vision screening at every well child visit
• Evaluate hearing: consider repeat ABR testing at 4–6 months or perform behavioral diagnostic 
testing at age 9 months if ABR is not done at 4-6 months  
• Provide referrals: Any children with identified or suspected delays should be referred to a 
developmental specialist or early intervention programs 
• Provide family support services, such as counseling, as needed
Family and Psychosocial Support
• Families and caregivers of infants with congenital Zika virus infection may require 
ongoing psychosocial support.
• Families should be empowered to be active participants in their child’s monitoring 
and care.
• Healthcare providers should work closely with parents to ensure that the care plan 
is consistent with the infant’s needs and the family’s wishes.
• Families with already limited access to medical care might be affected with a 
disproportionate burden of Zika virus infection.
• Barriers to care for all affected infants and their families should be addressed by 
linking them with national, state, and local health programs as well as social 
services.
• Additional resources for families can be found at: 
http://www.cdc.gov/zika/parents/families-of-newborns-affected-zika.html
Pediatric Evaluation and Follow-up Tools
Initial Evaluation and Outpatient Management During the First 12 Months of Life for 
Infants with Possible Congenital Zika Virus Infection
Download at: 
http://www.cdc.gov/zika/pdfs/p
ediatric-evaluation-follow-up-
tool.pdf
Zika Virus and Caring for Infants and Children
Infants with Possible Postnatal Zika Virus Infection
• Guidance for testing and clinical management of infants and children with postnatal 
Zika virus infection is in line with testing and clinical management recommendations 
for adults.
• Symptomatic treatment and supportive care are appropriate and usually sufficient to 
treat Zika. Special considerations to treat children with Zika include 
• Aspirin should never be used to treat children with symptoms of acute viral illness 
because of the risk of Reye’s syndrome.
• All non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided in children 
<6 months.
• Patients with suspected Zika virus infections should be evaluated and managed for 
possible dengue or chikungunya virus infection.
• Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) should be 
avoided until dengue can be ruled out 
Zika and Breastfeeding
• Transmission of Zika virus through breast milk 
has not been documented.
• Benefits of breastfeeding outweigh theoretical 
risk of Zika virus transmission through breast 
milk
• CDC and the World Health Organization 
recommend that infants born to women with 
suspected, probable, or confirmed Zika virus 
infection, or who live in or have traveled to 
areas of Zika, should be fed according to usual 
infant feeding guidelines.
Tips for Parents and Caregivers
• Dress your child in clothing that covers arms 
and legs.
• For children older than 2 months, use insect 
repellent on exposed skin.
» Do not use insect repellent on babies younger 
than 2 months old.
• Cover crib, stroller, and baby carrier with 
mosquito netting.
Tips for Parents and Caregivers
Adults applying insect repellent for babies and 
children
• Do not apply repellent onto hands, eyes, 
mouth, and cut or irritated skin.
• Spray onto your hands and then apply to a 
child’s face.
• Do not use products containing oil of lemon 
eucalyptus or para-menthane-diol on children 
younger than 3 years old.
Resources for Healthcare Providers
• Caregivers of children with Zika-related complications are often overwhelmed and 
may need support, guidance, and help establishing a medical home.
• Healthcare providers should work closely with and empower parents and families to 
monitor their infant’s development and determine what choices are available and 
how to best care for their infant’s condition and needs.
• Resources and guidance for healthcare providers caring for infants affected by Zika
virus are available on the CDC website. 
http://www.cdc.gov/zika/hc-providers/infants-children/resources-hc-providers-caring-for-infants.html
Resources for Families 
For more resources to share with families visit http://www.cdc.gov/zika/hc-providers/infants-children/resources-hc-providers-caring-for-infants.html.  
Available in English, Spanish and other languages 
What is CDC Doing? 
Many Questions Remain
• What is the level of risk from a Zika virus infection 
during pregnancy?
• When during pregnancy does Zika virus infection 
pose the highest risk to the fetus?
• What is the full range of potential health problems 
that Zika virus infection may cause?
• What other factors (e.g., co-occurring infection, 
nutrition, symptomatic vs. asymptomatic) might 
affect the risk for birth defects?
• What is the risk for later health problems in an 
infant who is infected or who has had exposure to 
Zika virus but is born without abnormalities?
Collecting Data for Action
Surveillance of Zika and its Effects on Pregnant Women, Infants, & Children
US Zika Pregnancy 
Registry
Zika Active Pregnancy 
Surveillance System 
(Puerto Rico) 
Proyecto Vigilancia de 
Embarazadas con Zika 
(Colombia)
US Zika-Related Birth 
Defects Surveillance
ArboNET Surveillance 
of Children with 
Postnatal Zika
Sharing Up-to-Date Information
• Providing updated clinical guidance
• Responding to your inquiries:
• Email: ZikaMCH@cdc.gov
• Zika Pregnancy Hotline: 770-488-7100
• CDC-INFO: (800-232-4636) 
http://www.cdc.gov/zika
Developing Tools for Healthcare Providers
www.cdc.gov/Zika
*Free materials available in English, Spanish and other languages
What Can You Do?
Report Confirmed or Probable Cases of Zika
• Zika virus infection and disease are nationally 
notifiable conditions.
• Healthcare providers should report laboratory-
confirmed and symptomatic cases of Zika to the local, 
state or territorial health department which in turn 
should report the case ArboNET.
Report Cases to US Zika Pregnancy Registry 
• Healthcare providers are encouraged to report and actively monitor 
pregnancies and congenital outcomes among symptomatic and 
asymptomatic women with laboratory evidence of possible Zika virus 
infection 
• More information
• Available on the US Zika Pregnancy Registry website
(http://www.cdc.gov/zika/hc-providers/registry.html) 
• To contact CDC Registry staff, call the CDC Emergency Operations Center 
watch desk at 770-488-7100 and ask for the Zika Pregnancy Hotline or email 
ZIKApregnancy@cdc.gov
• For non-urgent requests, call 800-CDC-INFO (800-232-4636)
In Summary
• Know the basics about Zika transmission in your community
• Diagnose and test for Zika for those with symptoms in your community
• Understand the assessment and management of Zika among pregnant 
women and infants
• Recommend Zika prevention behaviors 
• Provide support for families of infants affected by Zika 
• Inform your local or state health department to help keep ArboNET and the 
US Zika Pregnancy Registry up-to-date
More Information about Zika
More information on caring for pregnant women, infants, or children with Zika 
virus infection is available at CDC's Zika website.
www.cdc.gov/zika
For more information, contact CDC
1-800-CDC-INFO (232-4636)
TTY:  1-888-232-6348    www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the 
official position of the Centers for Disease Control and Prevention.
Thank you!
More information on Zika: www.cdc.gov/zika
